Concepts (43)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antineoplastic Agents | 3 | 2016 | 48 | 0.910 |
Why?
|
| Antibodies, Monoclonal | 2 | 2016 | 30 | 0.540 |
Why?
|
| Direct-to-Consumer Advertising | 1 | 2016 | 1 | 0.490 |
Why?
|
| Medical Oncology | 1 | 2016 | 10 | 0.480 |
Why?
|
| Immunotherapy | 1 | 2013 | 10 | 0.390 |
Why?
|
| Molecular Targeted Therapy | 1 | 2013 | 7 | 0.390 |
Why?
|
| Melanoma | 1 | 2013 | 16 | 0.390 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2024 | 37 | 0.330 |
Why?
|
| Lung Neoplasms | 2 | 2024 | 87 | 0.320 |
Why?
|
| Body Composition | 1 | 2024 | 31 | 0.210 |
Why?
|
| Sarcoma, Synovial | 1 | 2022 | 5 | 0.180 |
Why?
|
| Sarcoma | 1 | 2022 | 19 | 0.180 |
Why?
|
| Humans | 7 | 2024 | 5837 | 0.170 |
Why?
|
| Neoplasms | 1 | 2016 | 39 | 0.120 |
Why?
|
| Neoplasm Metastasis | 2 | 2013 | 23 | 0.110 |
Why?
|
| United States | 1 | 2016 | 502 | 0.100 |
Why?
|
| Forecasting | 1 | 2013 | 23 | 0.100 |
Why?
|
| Body Weight | 2 | 2024 | 48 | 0.080 |
Why?
|
| Animals | 1 | 2013 | 1349 | 0.080 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2008 | 5 | 0.070 |
Why?
|
| Female | 4 | 2024 | 3346 | 0.070 |
Why?
|
| Retrospective Studies | 2 | 2022 | 584 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2007 | 3 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2007 | 3 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2007 | 4 | 0.060 |
Why?
|
| Receptor, ErbB-2 | 1 | 2007 | 12 | 0.060 |
Why?
|
| Breast Neoplasms | 1 | 2007 | 69 | 0.060 |
Why?
|
| Male | 3 | 2024 | 3399 | 0.060 |
Why?
|
| Aged | 2 | 2024 | 1860 | 0.060 |
Why?
|
| Neoplasm Staging | 1 | 2024 | 74 | 0.050 |
Why?
|
| Body Mass Index | 1 | 2024 | 111 | 0.050 |
Why?
|
| Middle Aged | 2 | 2024 | 1775 | 0.050 |
Why?
|
| Margins of Excision | 1 | 2022 | 12 | 0.040 |
Why?
|
| Time Factors | 1 | 2022 | 374 | 0.040 |
Why?
|
| Adult | 1 | 2022 | 1670 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2017 | 11 | 0.030 |
Why?
|
| Leukocyte Count | 1 | 2017 | 19 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 35 | 0.030 |
Why?
|
| Neutrophils | 1 | 2017 | 31 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2008 | 10 | 0.020 |
Why?
|
| Trastuzumab | 1 | 2007 | 10 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2007 | 16 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2008 | 1034 | 0.010 |
Why?
|